Liquid embolics

Onyx™ liquid embolic system

<p>The Onyx™ liquid embolic system (LES) is an injectable, non-adhesive agent used for presurgical embolization of brain arteriovenous malformations (bAVMs).</p>

Features

Control2

Cohesive deposition

Provides a responsive, controlled injection of Onyx™ LES to achieve nidal penetration

Visibility2

Know where it flows

Provides live feedback of the embolic fill & trajectory, enabling visibility of Onyx™ injection under fluoroscopy

Evidence3,4

Market Leader

330+ publications on Onyx™ LES and on market for 19 years

Onyx™ LES is available in different formulations and viscosities1

The numerical term of Onyx™ LES describes its relative viscosity. Onyx™ LES is offered in 18 and 34 to provide options for controllable injections.

onyx fluid still neon

Onyx™ LES compatible flow-directed micro catheters

The Apollo™ Onyx™ and Marathon™,‡ delivery micro catheters have been expressly designed to complement and enhance embolization with Onyx™ LES. These synergistic tools help you journey to more tortuous locations, embolize more challenging lesions, and return with confidence.5-7

Marathon™ and Apollo™ flow-directed catheters have been expressly designed to complement and enhance embolization with Onyx™ LES.

Ordering information

Onyx™ liquid embolic system

Item number Description
105-7100-060 Onyx™ 18 formulation kit contains: 1.5 mL vial of Onyx™ LES, 1.5 mL vial of DMSO, 1 mL DMSO syringe, 2X
105-7100-080 Onyx™ 34 formulation kit contains: 1.5 mL vial of Onyx™ LES, 1.5 mL vial of DMSO, 1 mL DMSO syringe, 2X

Onyx™ liquid embolic system accessories

Item number Description Units per box
103-1205-001 Vial mixer, 15–17 mm, 110 V 1
103-1205-002 Vial mixer, 15–17 mm, 240 V 1

† Please note that some of these studies were conducted OUS and may not comply with the U.S. indications for use. See IFU for U.S. indication.

‡ Based on bench testing. May not be representative of clinical performance.

  1. Onyx™ Liquid Embolic System IFU, 70862-001 Rev 10/13.
  2. Based on internal design verification test report #TR02-092 Rev A, Low Density Onyx™ (18, 20, and 34) with Increased Tantalum Concentrations. 
  3. Onyx™ LES PMA #P030004.
  4. Based on internal clinical evaluation (literature review) report #TR-NV12982 Rev L, Onyx™ LES, 1 mL Onyx™ LES Delivery Syringe, and Onyx Syringe Catheter Interface Adaptor.
  5. Apollo™ Onyx™ Delivery Micro Catheter IFU, 70556-001 Rev. 05/13.
  6. Based on internal design verification test report #TR03-106 Rev A, Marathon™ AVM Catheter Model #: 105-5055.
  7. Meyers PM et al., Safety of the Apollo™ Onyx™ delivery microcatheter for embolization of brain arteriovenous malformations: results from a prospective post-market study. J Neurointerv Surg. 2021 Oct;13(10):935-941. doi: 10.1136/neurintsurg-2020-016830. Epub 2021 Feb 1. PMID: 33526480.